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Abstract: The expression and activity of DNA-dependent protein kinase (DNA-PK) is related to
DNA repair status in the response of cells to exogenous and endogenous factors. Recent studies
indicate that Epidermal Growth Factor Receptor (EGFR) is involved in modulating DNA-PK. It has
been shown that a compound 4-nitro-7-[(1-oxidopyridin-2-yl)sulfanyl]-2,1,3-benzoxadiazole (NSC),
bearing a nitro-benzoxadiazole (NBD) scaffold, enhances tyrosine phosphorylation of EGFR and
triggers downstream signaling pathways. Here, we studied the behavior of DNA-PK and other
DNA repair proteins in prostate cancer cells exposed to compound NSC. We showed that both
the expression and activity of DNA-PKcs (catalytic subunit of DNA-PK) rapidly decreased upon
exposure of cells to the compound. The decline in DNA-PKcs was associated with enhanced protein
ubiquitination, indicating the activation of cellular proteasome. However, pretreatment of cells with
thioglycerol abolished the action of compound NSC and restored the level of DNA-PKcs. Moreover,
the decreased level of DNA-PKcs was associated with the production of intracellular hydrogen
peroxide by stable dimeric forms of Cu/Zn SOD1 induced by NSC. Our findings indicate that
reactive oxygen species and electrophilic intermediates, generated and accumulated during the redox
transformation of NBD compounds, are primarily responsible for the rapid modulation of DNA-PKcs
functions in cancer cells.
Keywords: DNA-PKcs; DNA repair; hydrogen peroxide; SOD1; nitro-benzoxadiazole;
chemiosensitization; protein targeting; prostate cancer
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1. Introduction
DNA damage caused by different endogenous and exogenous factors triggers signaling and repair
pathways, which are vital for the maintenance of genome integrity [1]. DNA double-strand breaks
(DSBs) are considered the most cytotoxic DNA lesions; they result from endogenous events such as
V(D)J recombination and the production of reactive oxygen species (ROS) during cellular metabolism,
as well as from exogenous sources such as ionizing radiation and radiomimetic drugs [2]. The two main
mechanisms by which cells repair DSBs are non-homologous end joining (NHEJ) and homologous
recombination (HR). During NHEJ, the two broken ends of DNA are pieced together, sometimes
after limited processing of these ends, resulting in quick error-prone repair [3]. The core components
of NHEJ include DNA-dependent protein kinase (DNA-PK), which is composed of DNA-binding
subunits (Ku70 and Ku86) and a catalytic subunit (DNA-PKcs), DNA ligase IV, the nuclease Artemis,
and XRCC4 [4].
The 450-kDa DNA-PKcs is a key protein in the NHEJ pathway of DSB repair [2]. On the basis of
sequence comparison, DNA-PKcs has been classified as a member of the phosphatidylinositol-3-kinase
(PI-3-K)-related kinase (PIKK) super family of proteins [5], which also includes the ataxia telangiectasia
mutated (ATM) and ATM-Rad3 related (ATR) proteins [6,7]. The role of DNA-PKcs in DNA-damage
NHEJ and HR repair pathways, and its more recently discovered role in the regulation of the
homeostasis of cell proliferation, have been extensively studied [8]. DNA-PKcs, along with ATM
and ATR, is regarded more as a sensor of primary DNA damage than an inducible downstream
effector of DNA damage signaling. The activation of DNA-PKcs may involve interactions with
DNA and other proteins [9]. DNA-PKcs is abundantly expressed in almost all mammalian cells,
is considered to be a predominantly nuclear protein, and appears to be present together with the
Ku70/80 heterodimer in lipid rafts [10]. DNA-PKcs is subject to autophosphorylation and is involved
in the phosphorylation of a range of protein substrates, including H2AX, p-53, Replication Protein
A (RPA), and Artemis [4,11–14]. Recent findings indicate that the epidermal growth factor receptor
(EGFR) is involved in modulating DNA double-strand break repair by NHEJ beyond modifying
proliferation, survival, metastasis, and angiogenesis [15,16]. This modulation is especially important
in tumors characterized by substantial over-expression of EGFR [17,18], including prostate cancer,
in which the progression of the normal epithelium to an androgen-dependent tumor involves the
activation of EGFR [19]. The efficiency of NHEJ is stimulated by a truncated EGFRvIII variant of the
receptor, and reduced by EGFR-specific inhibitors in treated cells [20]. Experimental results have
indicated that EGFR activation by various stimuli, such as ionizing radiation, ligand stimulation, heat
shock, H2O2, and cisplatin, leads to the internalization of the receptor and its nuclear translocation,
together with DNA-PK subunits [15]. The EGFR-mediated stimulation of DSB rejoining could be
due to an increase in the nuclear content of DNA-PK subunits and hence an increase in the activity
of the DNA-PK-dependent non-homologous end-joining (D-NHEJ) system [20]. Furthermore, it has
been demonstrated that blocking EGFR-mediated signaling by cetuximab, an anti-EGFR monoclonal
antibody, or by BIBX1382BS, a tyrosine kinase inhibitor of ErbB, results in a decrease in DNA-PK
activity and sequestration of DNA-PK into the cytosol [21–24].
Recently, we have developed small molecule microarrays to screen chemical compound libraries
with the goal of selecting molecules able to bind to the extracellular region of EGFR [25]. Among
these small molecule binders, the compound NSC 228155 (referred to as NSC hereafter, Figure S1)
carrying a nitro-benzoxadiazole (NBD) ring has been identified as an attractive non-peptide molecule
that rapidly enhances tyrosine phosphorylation of EGFR and triggers downstream signaling pathways
in cancer cells. However, the enhanced tyrosine phosphorylation of EGFR by NSC has been shown
to be associated with the inhibition of protein phosphatase activity, suggesting that reactive oxygen
species (ROS) contribute to activating the receptor [25].
In this study, we focus on the action of NSC on DNA damage repair proteins in prostate cancer
cells. We show that exposure of cells to NSC leads to the rapid modulation of DNA-PKcs and other
PIKK proteins. Our results reveal that the response of DNA repair proteins is primarily caused
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by reactive molecules generated during redox transformation of NSC in exposed cells. We also
demonstrate that pretreatment of cancer cells with NSC sensitizes them to camptothecin-induced
DNA breaks.
2. Results
2.1. NSC Treatment Rapidly Affects the Amount of DNA-PKcs Protein
The amounts of major DNA repair proteins were assessed in prostate cancer cell lines PC-3
and DU145 treated by the small molecule NSC using Western immunoblotting. No difference was
detected in the amounts of the DNA-binding subunits KU70 and KU80 of DNA-PK compared to the
control and EGF treatment (Figure 1A). However, a clear decrease was found in the amount of the
catalytic subunit of the protein, DNA-PKcs, in the same cells after exposure to 100 µM NSC for 5, and
especially for 10 min. The relative amount of DNA-PKcs was lower in PC-3 than in DU145-treated
cells, corresponding to a decrease of 40% and 20%, respectively (Figure 1B). None of the other DNA
repair proteins tested, namely RAD51, PARP, PCNA, and MRE11, showed a significant difference in
NSC-treated PC-3 and DU145 cells compared to untreated cells after 5 and 10 min of exposure (see
Figure 1A). Meanwhile, the level of phosphorylated EGFR at Y1068 was enhanced in cells exposed to
NSC or EGF (control), whereas the total amount of the receptor was not affected (Figure 1B).
In addition, the level of DNA-PKcs expression was assessed in PC-3 cells after exposure to NSC at
lower concentrations and longer incubation times, up to 72 h. In contrast to EGFR, a gradual decrease
in the DNA-PKcs protein level was observed (Figure 1C), indicating that the small molecule action on
DNA-PKcs is dose-dependent and might have a cumulative effect on NHEJ repair efficiency and the
viability of treated cells.
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2.2. Subcellular Distribution of DNA-PKcs
The subcellular distribution of DNA-PKcs in PC-3 and DU145 cells exposed to NSC was examined
by immunostaining with an antibody specifically recognizing the catalytic subunit of the protein.
Before NSC treatment, DNA-PKcs was mainly localized in the nucleus, which was stained with DAPI.
After NSC incubation for 10 min, there was a visible decrease in DNA-PKcs protein levels in PC-3
and DU145 cells compared to non-treated control cells (Figure 2A,B). This result is consistent with
the Western-blot analysis showing a weak fluorescence signal from DNA-PKcs in NSC-treated cells
(Figure 1A). There was no apparent change in the subcellular distribution of DNA-PKcs under the
measurement conditions used in Figure 2A,B. However, when a higher-resolution imaging was used,
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DNA-PKcs appeared to be distributed inside PC-3 cells shortly after exposure to NSC (Figure 2C).
The fluorescent signal from DNA-PKcs had an essentially nuclear localization in control cells, whereas
as little as a 5-min exposure to NSC resulted in the appearance of the protein-specific signal from the
cytoplasm of many cells. This tendency became more clearly visible after a 10-min, 20-min and 30-min
of exposure to NSC, indicating that DNA-PKcs was diffused in the cells.
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DU145 (B) cells exposed to 100 µM NSC (NSC) or to vehicle (Control) for 10 min; (C) DNA-PKcs
intracellular distribution in PC-3 was also analyzed after NSC treatment at 100 µM for 5, 10, 20 and
30 min. The treated and untreated cells were fixed and stained with anti-DNA-PKcs antibody (red
color). The nuclei were stained with DAPI (blue color).
Thus, a short exposure of cells to NSC results in a rapid decrease in the amount of nuclear
DNA-PKcs, which is accompanied by delocalization of the protein into the cytoplasm of treated cells.
2.3. Exposure to NSC Alters the Activity of DNA-PKcs
Because of the low yield of phosphorylated forms of DNA-PKcs, the phosphorylation level of
the protein was difficult to assess by Western blotting (Figure S3). Therefore, DNA-PKcs activity was
evaluated indirectly by estimating the phosphorylati n level of its substrate-protein RPA2. T address
this, camptothecin (CPT), a lective topoisomerase I poison, was used as it promotes DNA-PK
activation and subsequent RPA2 phosphorylation after treatment [26].
As shown in Figure 3A, 1-h of treatment of PC-3 cells with 100 µM i duced he phosphorylation
of RPA2, which could b detected s bands with diffe ent migration velocities. Thes bands correspond
to the intermediate and hyperphosphorylation status of RPA2 and the latter (the band with a lower
migration) is directly related to DNA-PKcs activity [27]. In fact, pre-incubation with the inhibitor
NU7441 strongly decreased this phosphorylated form of RPA2 indicating that DNA-PKcs activity was
reduced in cells after CPT treatment (Figure 3A).
Next, PC-3 cells were pre-incubated with 0.1 mM CPT for 20 h, and then incubated with NSC
at 10 µM for 1 h, or at 100 µM for 10 min. Western blotting analysis revealed that exposure to NSC
remarkably decreased the phosphorylation of RPA2 in CPT pretreated cells in the conditions used
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(Figure 3B). These data indicate that NSC leads to rapid attenuation of the kinase activity of DNA-PK
after CPT treatment in prostate cancer cells.Int. J. Mol. Sci. 2016, 17, 703 6 of 16 
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PC-3 cells exposed to NSC. (A) PC-3 cells were incubated with 1 µM NU7441 (DNA-PKcs inhibitor) for
1 h, and then incubated with 100 µM CPT (topoisomerase I inhibitor) for 1 h. Phosphoryl ted f rms of
RPA were detected with an i-RPA2 and anti-pT21-RPA2; (B) Af er pre-incubation of serum-starved cells
with 10´4 M CPT for 20 h and further incubation with 10 µM NSC for 1 h or 100 µM NSC for 10 min,
the DNA-PKcs activity was analyzed by comparing the fluorescent intensity of phosphorylated RPA2
(hyperphosphorylation status) with anti-pT21-RPA2 antibody. α-Tubulin was used as an internal control.
2.4. Exposure to NSC Promotes Protein Ubiquitination
Previously, we showed that tyrosine phosphorylation (Tyr774) of the adaptor protein c-CBL
located downstream of EGFR in the ubiquitination cascade was slightly increased in breast cancer
cells shortly aft exposure to compound NSC [25]. The pro easome-mediated pr teolytic pat way is
characterized by polyubiquitin chain formation on target proteins [27]. To find out whether the decrease
in the amount of DNA-PKcs in cells after exposure to NSC is related to protein degradation, total protein
ubiquitination was compared in non-treated and treated cells. Cell lysates of the samples obtained after
exposure to NSC or EGF (control) were analyzed by Western blotting using an anti-ubiquitin antibody.
It was observed that a 5-min and 10-min exposure to NSC in PC-3 or DU145 cells increased the
fluorescence intensity of protein bands, especially for the higher molecul r weight proteins, compared
to control cells and those having been exposed to the peptide ligand EGF (Figure 4). The ubiquitination
level was more pronounced in PC-3 cells than in DU145 cells.
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Figure 4. Assessment of protein ubiquitination in cancer cells exposed to EGF and NSC. Serum-starved
PC-3 and DU145 cells were expose to NSC (100 µM), or to EGF (150 ng/mL) for 5 or 10 mi . Cell lysates
were analyzed with anti-ubiquitin antibody recognizing ubiquitinated sites in proteins.
Int. J. Mol. Sci. 2016, 17, 703 7 of 16
These results show that NSC exposure rapidly promotes protein ubiquitination, which can activate
the cellular proteasome and further degradation of DNA-PKcs.
2.5. NSC Inhibits DNA-PK Activity Differently from a Proteasome Inhibitor
To better understand the mode of modulation of DNA-PKcs activity by NSC, protein degradation
was inhibited by pre-incubation of cells with a specific proteasome inhibitor. Previously, it was
shown that the compound MG-132 suppresses CPT-induced DNA-PKcs autophosphorylation, which
is specifically regulated by the proteasome in response to CPT [28]. PC-3 cells were incubated with one
of these compounds, i.e., CPT, NSC, or MG-132, or pretreated with CPT and then exposed to NSC or
MG-132, or treated consecutively with NSC and then MG-132 (Figure 5). CPT treatment alone enhanced
the phosphorylation of RPA2, as observed for the p-RPA2 intermediate and hyperphosphorylated
forms, and increased ATM phosphorylation, but did not affect the amount of DNA-PKcs synthesized
in the cells (Figure 5A, lane 3). As expected, incubation of cells with MG-132 strongly inhibited
RPA2 phosphorylation in the CPT-pretreated culture (Figure 5A, lane 6) and a similar inhibition was
detected after NSC exposure (Figure 5A, lane 7). Moreover, exposure to MG-132 or NSC decreased the
phosphorylation level of ATM in CPT-pretreated cells. However, as judged by comparing the signal
intensity recorded from the DNA-PKcs band in different samples, MG-132 pretreatment prevented the
NSC-promoted decline in this key repair protein in the cells (Figure 5A, lane 5). The suppression of the
action of NSC by the proteasome inhibitor is consistent with the assumption that NSC results in the
degradation of DNA-PKcs through proteasome activation in cells. CPT-associated NSC treatment also
decreased the ATM phosphorylation level (Figure 5A, lane 7), thus confirming the effect of NSC on the
PIKK protein family.
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Figure 5. Response of DNA-PKcs and ATM to exposure to NSC and proteasome inhibitor MG-132
in CPT-treated PC-3 cells. (A) Serum-starved cells were incubated with 10´4 M CPT alone for 20 h
and further exposed to NSC (100 µM for 10 min) or MG132 (25 µM for 1 h) alone or successively
to the two compounds. Two phosp orylated forms of RPA2 are indicated; h perphosphorylated
and int rmediate phosphory ated, which pres nt high and middle bands, respectiv ly. α-Tubulin
was used as an i t rnal control; (B) Schematic presentation of RPA2 phosphorylation routes through
Cyclin-dependent ki ases (CDKs) and PIKKs. CDKs contribute to RPA2 phosphorylation in a cell
cycle-specific manner. Hyperphosphorylation of RPA2 is dependent on PIKKs, including ATM and
DNA-PKcs.
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2.6. Thioglycerol Prevents the Action of NSC on DNA-PKcs
When this study was nearing completion, we revealed that the enhanced phosphorylation of
EGFR by NBD compounds is a result of the generation and action of hydrogen peroxide on the receptor
in breast cancer cells [29]. In particular, it was shown that lipophilic NBD compounds rapidly bind
to intracellular Cu/Zn superoxide dismutase 1 (SOD1) and thereby induce its dimerization and the
production of H2O2 in cells. Pre-incubation of cells with thioglycerol prevented SOD1 dimerization,
and the inactive enzyme was no longer able to convert the superoxide ion into H2O2.
To ascertain whether ROS are involved in the modulation of DNA-PKcs expression, the PC-3
culture was first pretreated with thioglycerol for 30 min and then exposed to NSC for 5 or 15 min.
Western-blot analysis showed that pre-incubation with the antioxidant almost completely restored
the amount of DNA-PKcs after 5-min of exposure to NSC, which was still clearly visible after 15-min
of exposure (Figure 6). It is noteworthy that the preventative effect of thioglycerol was accompanied
by the complete disappearance of SOD1 dimers. Besides, the decrease in the amount of DNA-PKcs
after pretreatment with thioglycerol was also accompanied by a decrease in the proteasome-specific
bands after 15-min of exposure to NSC that was not yet visible after 5-min of exposure. Meanwhile,
the amounts of the proteins Ku70 and gamma-H2AX remained unchanged in the cells pre-incubated
with thioglycerol, regardless of exposure to NSC.
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Figure 6. Pre-incubation with thioglycerol restores the level of DNA-PKcs by preventing dimerization
of SOD1 in cancer cells exposed to NSC. PC-3 cells were pre-incubated with 10 mM thioglycerol for
15 min then incubated with 100 µM NSC for 5 or 10 min. Proteins were analyzed by Western blotting
with the corresponding antibodies to detect DNA-PKcs, anti-SOD-1, ubiquitinated targets and γH2AX.
Ku70 was used as a negative control (see above) and α-tubulin as a loading control.
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To confirm the role of SOD1 in the diminution of DNA-PKcs expression after exposure to NSC,
we addressed MDA MB468 breast cancer cells, in which SOD1 was the knockdown with siRNA [29].
Western blotting revealed the presence of two bands corresponding to DNA-PKcs monomer and
dimer forms (or large complexes formed with other partners) in cells transfected with SOD1 siRNA or
scrambled siRNA (Figure S4). The amount of DNA-PKcs monomer forms prevails over dimers in cells
treated with vehicle, whereas the amount of DNA-PKcs dimers prevails over monomers after exposure
to NSC. However, the amount of both forms of DNA-PKcs was remarkably lower in cells transfected
with scrambled siRNA than with SOD1 siRNA after exposure to NSC. The diminution in the level
of DNA-PKcs in cells exposed to NSC correlated with the dimerization rate of SOD1 (see Figure S4).
Thus, these data indicate that the decrease in the level of DNA-PKcs occurs via rapid dimerization of
SOD1 by NSC. SOD1 is required to produce hydrogen peroxide, which is the reactive oxygen species
that modulates the expression level of DNA-PKcs.
2.7. NSC Can Sensitize Cancer Cell Lines to Camptothecin-Mediated DNA Damage
DNA-PKcs has been widely used as a target to sensitize cancer cells to small molecules exhibiting
anticancer potency [30–32]. Given that exposure to NSC attenuated the kinase activity of DNA-PK
in PC-3 cells pretreated with CPT (see above), it was tempting to improve the sensitivity of prostate
cancer cells to the topoisomerase I poison by pre-incubation of cells with NSC.
The viability of cancer cells was determined by incubating PC-3 and DU145 cells with different
concentrations of NSC for 72 h. This resulted in a significant reduction in the survival of cells with
IC50 values of 2.65 µM and 1.25 µM for PC-3 and DU145 cells, respectively (Figure 7). PC-3 cells were
more resistant to NSC exposure and were characterized by a higher amount of DNA-PK protein in
comparison to DU145 cells (see Figure 1A,B).
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Figure 7. PC-3 and DU145 cell survival is dose-dependent in NSC-treated cells. PC-3 cells (dashed gray
line) and DU145 cells (black line) were incubated with different concentrations of NSC for 72 h and
cellular viability was measured by the MTT method. The 50% inhibitory concentration (IC50) of NSC
was calculated by nonlinear regression analysis using GraphPad Prism software. The bars represent
the mean ˘ SD of 3 independent experiments.
Next, PC-3 cells were treated with 100 µM NSC for 10 min and then incubated with CPT for
48 h. Cell viability was assessed by the MTT method. As shown in Figure 8, CPT treatment after
exposure to NSC decreased the viability of PC-3 cells in comparison with CPT treatment alone.
This chemosensitizing effect was especially pronounced at 1 µM CPT. The ability of NSC to increase
the cytotoxicity of CPT in PC-3 cells leads us to suggest that this small compound acts through the
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modulation of DNA-PKcs functions and levels, apparently by altering the NHEJ repair system in cells
sensitized by camptothecin. However, the sensitization of PC-3 cells by NSC could be related with
targeting other vital proteins.Int. J. Mol. Sci. 2016, 17, 703 10 of 16 
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3. Discussion
Recently, we have described a new class of nitro-benzoxadiazole derivatives, which activate EGFR
and thereby trigger downstream signaling circuits in the cytoplasm and apparently in the nucleus of
breast cancer cells [25]. Here, we show that exposure of prostate cancer cell lines DU145, and especially
PC-3, to the compound NSC rapidly (within 5–10 min) reduced the amount and activity of DNA-PKcs
protein. Exposure to NSC sensitized prostate cancer cells to camptothecin-mediated DNA damage
in a time-dependent manner. The decrease in the amount of DNA-PK protein is not related to the
delocalization of DNA-PK subunits into the nucleus, unlike in EGF-induced cells [20]. In contrast,
this decrease is accompanied by a nuclear delocalization of DNA-PKcs into the cytoplasm, which
probably promotes rapid protein ubiquitination in cells exposed to NSC compared to a cognate ligand
EGF. Therefore, ubiquitin-mediated degradation of DNA-PKcs, the key partner of NHEJ, might affect
the functions of the protein required for interactions with DNA and other repair proteins.
DNA-PKcs is involved in the phosphorylation of a range of substrates, including H2AX, p-53,
RPA, and Artemis [4]. DNA-PKcs undergoes autophosphorylation within two distinct regions known
as the ABCDE (T2609, S2612, T2620, S2624, T2638, and T2647) and PQR (S2023, S2029, S2041, S2051,
S2053, and S2056) clusters [11–14]. Mutations of these phosphorylation sites result in ablated DSBs
repair and radiosensitivity in vitro and in vivo, suggesting that the autophosphorylation of DNA-PKcs
is critical for NHEJ efficiency. It therefore seems that other kinases are involved in its phosphorylation,
the main one being ATM, a member of the PIKK protein super family [33]. In addition, ATR is
responsible for the phosphorylation of T2609 and T2647 but phosphorylation of these residues, in
contrast to that of serine 2056, is not an appropriate marker for the activation of DNA-PKcs [33–36].
It is worth noting that all three proteins, i.e., ATM, ATR, and DNA-PK, are considered sensors of
primary DNA damage rather than inducible downstream effectors of DNA damage signaling [6,7].
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In this study, a remarkable diminution in RPA2 phosphorylation was observed upon NSC
treatment combined with CPT, indicating that the nitro-benzoxadiazole scaffold attenuates DNA-PKcs
kinase activity. Moreover, ATM phosphorylation (S1981) decreased upon NSC exposure in response
to DNA damage. Because of the low yield of DNA-PKcs phosphorylated protein forms, DNA-PKcs
activity was assessed by the phosphorylation rate of its substrate, RPA2, when cells were induced by a
selective topoisomerase I poison, CPT [26]. It has been demonstrated that RPA2 can be phosphorylated
in two ways: by a cyclin-dependent kinase (CDK) and by PIKKs (Figure 5B). CDKs contribute to
RPA2 phosphorylation in a cell cycle-specific manner [28]. In addition, several PIKKs, including
ATM and DNA-PK, are involved in the hyperphosphorylation of RPA2 [37,38]. The analysis of the
phosphorylated bands of RPA2 indicates that MG-132 suppresses RPA2 phosphorylation by PIKKs
(absence of a hyperphosphorylated RPA2 band in Figure 5A, lane 6, and explained in Figure 5B), but not
by CDK in CPT-treated cells, in agreement with the observations of other authors [28]. This is also
supported by findings that MG-132 pretreatment prevents RPA2 phosphorylation by CDK after further
exposure to NSC in CPT-incubated cells; on the contrary, when MG-132 is added to CPT-incubated
cells after NSC exposure, RPA2 phosphorylation by CDK is suppressed (Figure 5C). These results
suggest that NSC modulates CDK activity in addition to DNA-PKcs by the proteasome machinery in
cancer cells.
We have recently shown that lipophilic NBD compounds rapidly move through the cytoplasm
membrane and bind to Cu/Zn SOD1 leading to dimerization of the protein [29]. Stable dimers
of SOD1 are active and produce H2O2 that, in the absence of adequate modulation of catalase and
peroxidase activities, is accumulated within exposed cells (ibid). Note that hydrogen peroxide promotes
sulfenylation of a cysteine in the catalytic site of the protein tyrosine phosphatase 1B (PTP-1B), leading
to the inactivation ofi the enzyme [39], and also promotes the sulfenylation of a cysteine in the
catalytic site of EGFR leading to the activation of the enzyme [40]; hence, both enzymes determine the
phosphorylation status of the receptor in cells. Therefore, the enhanced phosphorylation of EGFR is a
result of hydrogen peroxide action on the catalytic site of EGFR and that of PTP-1B in cells exposed to
NBD compounds [29].
Similarly, our data highlight that hydrogen peroxide is generated and accumulates during redox
transformation of the NBD compounds [29,41], and is involved in the decline in the level and activity
of DNA-PKcs in prostate cancer cells. In fact, given that thioglycerol prevents SOD1 dimerization by
NSC, the inactive enzyme cannot convert superoxide ions into H2O2 and, therefore the amount of
DNA-PKcs is almost restored in cells. This data is supported by SOD1 RNA interference in breast
cancer cells. Thus, we conclude that rapid modulation of this DNA-repair protein by NSC is primarily
related to the action of reactive H2O2, without involvement of EGFR functions.
Several scenarios can be suggested to explain the decrease in DNA-PKcs level in prostate
cancer cells due to the action of H2O2, which is rapidly accumulated within cells exposed to NSC.
Firstly, large quantities of intracellular H2O2 could immediately and directly target and degrade
DNA-PKcs; Secondly, hydrogen peroxide stimulates protein degradation by up-regulation of the
ubiquitin system [42]. In particular, it causes down-regulation of DNA-PKcs, which involves
trapping the DNA-topoisomerase II complex and the induction of DNA double-strand breaks in
salvicine-treated cells [43]. In this context, the cellular proteasome, which is activated by NSC, could
essentially contribute to the degradation of DNA-PKcs and other DNA repair protein targets; Thirdly,
the reduction of the nitro group in NBD compounds during redox cycling results in the formation of
two types of reactive molecules, i.e., ROS and electrophilic NBD intermediates [29,41].
Therefore, the decrease in the level of DNA-PKcs could be caused by electrophilic intermediates
of NSC during redox transformations. The binding of electrophiles to the protein-protein interaction
interface of DNA-PKcs could lead to the dimerization of the protein or the formation of a protein
complex with other partners. Such a large and stable protein complex is degraded as could be suggested
from observations in cells transfected with scrambled siRNA. Lastly, a reduction in the amount of
DNA-PKcs might be caused by other factors that still need to be identified. In any event, the function
Int. J. Mol. Sci. 2016, 17, 703 12 of 16
of DNA-PKcs, one of the key players in DNA repair, would be impaired, along with impaired functions
of SOD1 and EGFR, which must lead to aberrant signaling and aggravate oxidative and electrophilic
stress in cells exposed to NBD compounds, and probably to some reactive environmental pollutants.
Due to its broad protective role, alterations in DNA-PK activity correlate with a variation in cell
survival after radio- and chemotherapy, making this protein of great interest as a promising target for
drug development [15]. Given that cell exposure to NSC affects proteins important in DNA damage
signaling, it is plausible that a DNA repair defect may contribute to enhancing the cytotoxicity of
damaging agents like topoisomerase I poisons. In this context, we have shown that exposure to NSC
sensitizes PC-3 cells to CPT treatment. It is known that the activation of DNA-PK by CPT is strictly
S-phase specific, suggesting that DNA-PK might promote NHEJ repair of CPT-induced damage in
the S phase. Although the overall contribution of NHEJ to genomic stability in the S phase is still not
clear, several reports have shown that DNA-PKcs-deficient cells are sensitive to UV and CPT [26,44],
implying that DNA-PK might be required for stalled fork repair through HR or checkpoint activation,
which is necessary for cell survival. In addition to its role in NHEJ repair, DNA-PKcs is also involved
in the oxidative clustered DNA lesion repair [45] that could explain the ROS-mediated effect of NSC.
Further studying the action of reactive NBD compounds on DNA repair and related functions
could help in elucidation of the complexity of events involved in the sensitization of cancer cells to
anticancer agents.
4. Experimental Section
4.1. Chemicals and Antibodies
NSC 228155 (NSC) was obtained from the Drug Synthesis and Chemistry Branch of NCI
(Figure S1). Camptothecin (CPT), NU7441, MG132 and thioglycerol were purchased from Sigma
(St Louis, MO, USA). The anti-ATM and anti-RPA2 antibodies were purchased from Thermo Fisher
Scientific (Waltham, MA, USA). The anti-phospho(T21)RPA and anti-phospho(S2056)DNA-PKcs
antibodies were purchased from Abcam (Cambridge, UK); all others were purchased from Cell
Signaling Technology (Danvers, MA, USA).
4.2. Cell Culture
The prostate cancer cell lines, PC-3 and DU145, were grown in RPMI 1640 medium (Life
Technologies, Carlsbad, CA, USA) containing 10% fetal bovine serum, 100 U/mL penicillin and
100 µg/mL streptomycin under a humidified atmosphere containing 5% CO2 at 37 ˝C. If necessary,
PC-3 and DU145 cells (1.0–1.2 ˆ 106/mL) were serum-starved for 24 h, then seeded into 60-mm
culture dishes and treated with NSC alone or MG132 or camptothecin for the desired periods as
described below.
4.3. Cell Viability Assay and Chemical Treatments
Cell viability was assessed by the MTT assay (Sigma) following the manufacturer’s instructions.
Briefly, cells were seeded at 5ˆ 103/well in a 96-well plate for 18 h, and then incubated in serum-starved
RPMI 1640 medium for 24 h. Cell cultures were then treated with increasing concentrations of
NSC for 72 h. MTT was added to each well for 2 h, before being aspirated and replaced with
DMSO. The absorbance was recorded at 560 nm with a spectrophotometer system (Tecan, Männedorf,
Switzerland). Results were analyzed using Microsoft Excel by standardizing treated groups to
the untreated control. The IC50 was determined as the compound concentration leading to 50%
growth inhibition.
Cells were also treated with 0.1 mM camptothecin (CPT) for 2 h at 37 ˝C or 10 µM MG132 for 1 h
at 37 ˝C and then exposed to NSC as described in the corresponding sections. The ROS effect was
investigated on cells pre-incubated with 10 mM thioglycerol for 15 min before exposure to 100 µM
NSC for 5 or 15 min.
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4.4. Western Blotting
Cells were washed twice with ice-cold PBS and then lysed in lysis buffer (NP-40) on ice for
30 min. The soluble fraction of proteins was collected by centrifugation at 13,000ˆ g for 15 min at
4 ˝C. The protein concentration was determined with the Bicinchoninic acid protein assay kit (BioRad,
Hercules, CA, USA) and samples were either used immediately for assays or stored at ´80 ˝C.
Equal amounts of cellular lysate proteins (40 µg of total proteins) were separated by
electrophoresis on 10% SDS-polyacrylamide gels and transferred to nitrocellulose membranes (GE
Healthcare, Little Chalfont, UK). Membranes were blocked for 1 h in 0.1% TBS-Tween 20 containing
2.5% BSA and then incubated with mouse monoclonal antibodies (anti-DNA-PKcs, anti-RPA2,
anti-tubulin) or rabbit antibodies (anti-pATM, anti-ubiquitin). Protein bands were resolved by
fluorescence with anti-mouse Alexa-Fluor680 or anti-rabbit Alexa-Fluor680 secondary antibodies
(Life Technologies-Invitrogen). The signal intensity (pixel¨mm´2) of protein bands was quantified
using Odyssey software version 1.1 (Li-COR, Biosciences, Lincoln, NE, USA). α-Tubulin was used as a
loading control.
4.5. Immunofluorescence Microscopy
Cells were grown on coverslips (Life Technologies) at a density of 5 ˆ 103 cells per well in
medium (RPMI) supplemented with 10% fetal bovine serum (Gibco-Invitrogen) as described above,
then serum-starved for 24 h and treated with NSC for 10 min. Cells were washed once in PBS for
5 min and fixed with 4% paraformaldehyde in 0.01 M phosphate-buffered saline (PBS), pH 7.4 for
10 min. After three 5-min washes in PBS, cells were permeabilized with PBS containing 0.1% Triton
X-100 for 30 min, washed three times in PBS for 5 min, and then blocked in 2% BSA in PBS at room
temperature for 25 min. The fixed cells were incubated overnight in the same buffer containing 1:100
diluted anti-DNA-PKcs antibody at 4 ˝C. After three 5-min washes in PBS, slides were incubated in
a 1:400 TRITC anti-mouse fluorescent secondary antibody solution (Jackson, Lansing, MI, USA) for
1 h at room temperature in the dark. The slides were washed three times in PBS, counterstained and
mounted with ProLong Antifade with DAPI (4’,6-diamidino-2-phenylindole) (Life Technologies) and
coverslips were applied. The slides were viewed with a confocal microscope (Nikon A1RSi, Minato-ku,
Tokyo, Japan) and epifluorescence microscope (Nikon Eclipse E800). The images were recorded with
NIS Element software (Version 3.6, Nikon, Tokyo, Japan) and processed with the software ImageJ
(NIH, Bethesda, MD, USA). The specificity of the antibody staining was confirmed by incubating the
adjacent sections in the absence of the primary antibody.
4.6. Statistical Analysis
The results represent the average and standard deviation of three independent experiments.
Data are presented as means ˘ standard error of mean. Differences between the control and the treated
cells were assessed with the paired Student’s t-test, and p < 0.05 was considered statistically significant.
Data analysis was performed with Microsoft Excel.
5. Conclusions
Our results indicate that a reactive NBD compound rapidly and drastically reduces the level and
activity of DNA-PKcs and, alters the DNA repair system in cancer cells. The mechanism of action relies
on the generation of ROS and electrophilic species leading to the activation of protein degradation.
Notably, that NBD compound sensitizes prostate cancer cells to camptothecin. Therefore, developing
NBD derivatives that selectively target DNA-PKcs might be a promising way to sensitize cancer cells
in order to improve the efficiency of anticancer agents from a therapeutic perspective.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/17/5/
703/s1.
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ATM Ataxia Telangiectasia Mutated
ATR ATM-Rad3 Related
CDKs Cyclin-dependent kinases
CPT Camptothecin
DNA-PKcs DNA-dependent Protein Kinase catalytic subunit
DSBs DNA double-strand breaks
EGFR Epidermal Growth Factor Receptor
HR Homologous Recombination
NBD Nitro-BenzoxaDiazole
NHEJ Non-Homologous End Joining
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PIKK Phosphatidyl inositol 31 kinase-related kinases
PTP-1B Protein Tyrosine Phosphatase 1B
RPA Replication Protein A
ROS Reactive Oxygen Species
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